Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality

Infection and Immunity

Volumn 79, Issue 9, 2011, Pages 3677-3682

  Gaillard, M E ^a   Bottero, D ^a   Castuma, C E ^a   Basile, L A ^a   Hozbor, D ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PERTACTIN; PERTUSSIS TOXIN; VIRULENCE FACTOR;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARGENTINA; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; GENOTYPE; IMMUNOBLOTTING; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TYPE III SECRETION SYSTEM;

ALLELES; ANIMALS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; BORDETELLA PERTUSSIS; ENVIRONMENT; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; IMMUNOBLOTTING; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VIRULENCE FACTORS; WHOOPING COUGH;

EID: 80052313164     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00136-11     Document Type: Article

References (48)

1. Bottero, D., et al. 2007. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin. Vaccine Immunol. 14:1490-1498.
2. Bouchez, V., et al. 2009. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27:6034-6041.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Brinig, M. M., et al. 2006. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J. Bacteriol. 188:2375-2382.
5. Büttner, D., and U. Bonas. 2002. Port of entry-the type III secretion translocon. Trends Microbiol. 10:186-192.
6. Coburn, B., I. Sekirov, and B. B. Finlay. 2007. Type III secretion systems and disease. Clin. Microbiol. Rev. 20:535-549.
7. Cornelis, G. R. 1998. The Yersinia deadly kiss. J. Bacteriol. 180:5495-5504.
8. Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735-774.
9. Cummings, C. A., H. J. Bootsma, D. A. Relman, and J. F. Miller. 2006. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J. Bacteriol. 188:1775-1785.
10. de Greeff, S. C., et al. 2010. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5:e14183.
11. Fauconnier, A., et al. 2001. Characterization of the type III secretion locus of Bordetella pertussis. Int. J. Med. Microbiol. 290:693-705.
12. Fennelly, N. K., et al. 2008. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect. Immun. 76:1257-1266.
13. Fernández, J., F. Sisti, D. Bottero, M. E. Gaillard, and D. Hozbor. 2005. Constitutive expression of bvgR-repressed factors is not detrimental to the Bordetella bronchiseptica-host interaction. Res. Microbiol. 156:843-850.
14. Fingermann, M., et al. 2006. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 24:3513-3521.
15. Fux, C. A., M. Shirtliff, P. Stoodley, and J. W. Costerton. 2005. Can laboratory reference strains mirror "real-world" pathogenesis? Trends Microbiol. 13:58-63.
16. Galán, J. E. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53-86.
17. Galán, J. E., and A. Collmer. 1999. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284:1322-1328.
18. Ghosh, P. 2004. Process of protein transport by the type III secretion system. Microbiol. Mol. Biol. Rev. 68:771-795
19. Hamstra, H. J., B. Kuipers, D. Schijf-Evers, H. G. Loggen, and J. T. Poolman. 1995. The purification and protective capacity of Bordetella pertussis outer membrane proteins. Vaccine 13:747-752.
20. Han, H. J., A. Kuwae, A. Abe, Y. Arakawa, and K. Kamachi. 2011. Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. PLoS One 6:e17797.
21. Hot, D., et al. 2003. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol. Genet. Genomics 269:475-486.
22. Hsia, R. C., Y. Pannekoek, E. Ingerowski, and P. M. Bavoil. 1997. Type III secretion genes identify a putative virulence locus of Chlamydia. Mol. Microbiol. 25:351-359.
23. Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.
24. Kallonen, T., and Q. He. 2009. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev. Vaccines 8:863-875.
25. Kasuga, T., Y. Nakase, K. Ukishima, and K. Takatsu. 1954. Studies on Haemophilus pertussis. V. Relation between the phase of bacilli and the progress of the whooping-cough. Kitasato Arch. Exp. Med. 27:57-62.
26. Kirchner, O., and A. Tauch. 2003. Tools for genetic engineering in the amino acid-producing bacterium Corynebacterium glutamicum. J. Biotechnol. 104: 287-299.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
28. Le Blay, K., P. Gueirard, N. Guiso, and R. Chaloy. 1997. Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica. Microbiology 143:1433-1441.
29. Mattoo, S., M. H. Yuk, L. L. Huang, and J. F. Miller. 2004. Regulation of type III secretion in Bordetella. Mol. Microbiol. 52:1201-1214.
30. Medhekar, B., R. Shrivastava, S. Mattoo, M. Gingery, and J. F. Miller. 2009. Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivo. Mol. Microbiol. 71:492-504.
31. Michiels, T., P. Wattiau, R. Brasseur, J. M. Ruysschaert, and G. Cornelis. 1990. Secretion of Yop proteins by Yersiniae. Infect. Immun. 58:2840-2849.
32. Mooi, F. R. 2010. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 10:36-49.
33. Mooi, F. R., I. H. van Loo, and A. J. King. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526-528.
34. Mooi, F. R., et al. 2009. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg. Infect. Dis. 15: 1206-1213.
35. Parsot, C., R. Menard, P. Gounon, and P. J. Sansonetti. 1995. Enhanced secretion through the Shigella flexneri Mxi-Spa translocon leads to assembly of extracellular proteins into macromolecular structures. Mol. Microbiol. 16:291-300. 33a
36. Pittman, M. 1984. Genus Bordetella, p. 388-393. In N. R. Krief and J. G. Holt (ed.), Bergey's manual of systemic bacteriology, vol. 1. Williams and Wilkins Company, Baltimore, MD.
37. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
38. Stefanelli, P., et al. 2006. Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates. J. Clin. Microbiol. 44:3397-3400.
39. Stibitz, S., and M. S. Yang. 1997. Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping. J. Bacteriol. 179:5820-5826.
40. Stibitz, S., and M. S. Yang. 1999. Genomic plasticity in natural populations of Bordetella pertussis. J. Bacteriol. 181:5512-5515.
41. Troisfontaines, P., and G. R. Cornelis. 2005. Type III secretion: more systems than you think. Physiology (Bethesda) 20:326-339.
42. van Boven, M., F. R. Mooi, J. F. Schellekens, H. E. de Melker, and M. Kretzschmar. 2005. Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc. Biol. Sci. 272:1617-1624.
43. Van den Ackerveken, G., and U. Bonas. 1997. Bacterial avirulence proteins as triggers of plant disease resistance. Trends Microbiol. 5:394-398.
44. Viboud, G. I., and J. B. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59:69-89.
45. Viprey, V., A. Del Greco, W. Golinowski, W. J. Broughton, and X. Perret. 1998. Symbiotic implications of type III protein secretion machinery in Rhizobium. Mol. Microbiol. 28:1381-1389.
46. von Götz, F., et al. 2004. Expression analysis of a highly adherent and cytotoxic small colony variant of Pseudomonas aeruginosa isolated from a lung of a patient with cystic fibrosis. J. Bacteriol. 186:3837-3847.
47. Yuk, M. H., E. T. Harvill, P. A. Cotter, and J. F. Miller. 2000. Modulation of host immune responses, induction of apoptosis and inhibition of NF- B activation by the Bordetella type III secretion system. Mol. Microbiol. 35: 991-1004.
48. Yuk, M. H., E. T. Harvill, and J. F. Miller. 1998. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. tMol. Microbiol. 28:945-959